Wellumio
Wellington, New Zealand
◆ Total Raised
$9.8M
◆ Stage
seed
◆ Location
Wellington, New Zealand
◆ Founded
2022
◆ Team size
11-50
◆ Links
◆ About Wellumio
Wellumio is developing Axana, a portable brain imaging system for point-of-care stroke detection.
◆ What sets it apart
Its portable MRI-based system uses proprietary PGFM technology to enable bedside stroke imaging without traditional MRI infrastructure such as helium cooling or RF-shielded rooms.
◆ Sectors
◆ Business
Modelhardware
CustomerHospitals, emergency departments, stroke care teams, and healthcare providers needing rapid brain imaging at the point of care
◆ Notable
- Co-founded in early 2022
- Enrolled the first patient in an Australian clinical trial for Axana
- Raised an oversubscribed $9.75M pre-Series A round
- Secured a U.S. patent for its imaging technology
◆ Funding rounds
◆ Explore the market
◆ FAQ
What does Wellumio do?
Wellumio is developing Axana, a portable brain imaging system for point-of-care stroke detection.
Where is Wellumio based?
Wellumio is based in Wellington, New Zealand, founded in 2022.
How much has Wellumio raised?
Wellumio has raised $9.8M in tracked funding and is currently at the seed stage.
Who has invested in Wellumio?
Investors in Wellumio include Nuance Connected Capital, Icehouse Ventures, NZGCP Aspire Seed Fund, Pacific Channel, Booster, Cure Kids Ventures, Enterprise Angels and Flying Kiwi.